P08195 (4F2_HUMAN) Homo sapiens (Human)
Amino acid transporter heavy chain SLC3A2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
However, an attempt to improve models for this target was made on 2025-05-02. The outcome - failed for technical reasons.
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Overall structure of the LAT1-4F2hc bound with JX-075 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HNX; 2×Y01; | |||
| Overall structure of the LAT1-4F2hc bound with JX-078 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HO0; 2×Y01; | |||
| Overall structure of the LAT1-4F2hc bound with JX-119 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HO9; 2×Y01; | |||
| Overall structure of the y+LAT1-4F2hc bound with Arg |
Heteromer Q9UM01; | 100 | 4×NAG; 1×ARG; | |||
| Local refinement of the y+LAT1-4F2hc bound with Arg |
Heteromer Q9UM01; | 100 | 4×NAG; 1×ARG; | |||
| Structure of y+LAT2 bound with Arg |
Heteromer Q92536; | 100 | 1×ARG; | |||
| Overall structure of the y+LAT2-4F2hc bound with Leu |
Heteromer Q92536; | 100 | 1×LEU; | |||
| Overall structure of the LAT1-4F2hc bound with 3,5-diiodo-L-tyrosine |
Heteromer Q01650; | 100 | 4×NAG; 1×TYI; 2×Y01; 1×3PH; | |||
| Overall structure of the LAT1-4F2hc bound with JPH203 |
Heteromer Q01650; | 100 | 4×NAG; 1×VRW; | |||
| Overall structure of the LAT1-4F2hc bound with Leu |
Heteromer Q01650; | 100 | 4×NAG; 1×LEU; | |||
| Overall structure of the LAT1-4F2hc bound with tyrosine |
Heteromer Q01650; | 100 | 4×NAG; 1×TYR; | |||
| The LAT2-4F2hc complex in complex with tryptophan |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×TRP; 2×3PH; | |||
| The LAT2-4F2hc complex in complex with leucine |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×LEU; 2×3PH; | |||
| Overall structure of the LAT1-4F2hc bound with L-dopa |
Heteromer Q01650; | 100 | 4×NAG; 1×DAH; | |||
| Overall structure of the LAT1-4F2hc bound with tryptophan |
Heteromer Q01650; | 100 | 4×NAG; 1×TRP; | |||
| Consensus mutated xCT-CD98hc complex |
Heteromer Q9UPY5; | 100 | ||||
| human LAT1-4F2hc complex incubated with JPH203 |
Heteromer Q01650; | 100 | 4×NAG; 2×3PH; | |||
| human LAT1-4F2hc complex bound with BCH |
Heteromer Q01650; | 100 | 4×NAG; 2×3PH; 1×AUU; | |||
| Cryo EM map of SLC7A10 with L-Alanine substrate |
Heteromer Q9NS82; | 100 | 1×NAG; 3×NAG; 1×ALA; | |||
| Human LAT2-4F2hc complex in the apo-state |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×AJP; | |||
| Structure of apo inward-open LAT1-CD98hc-Fab170 in nanodisc, consensus map |
Heteromer Q01650; | 100 | 4×NAG; | |||
| Structure of LAT1-CD98hc-Fab170 in complex with BCH, consensus map |
Heteromer Q01650; | 100 | 4×NAG; 1×VU0; | |||
| Structure of LAT1-CD98hc-Fab170 in complex with JPH203, consensus map |
Heteromer Q01650; | 100 | 4×NAG; 1×VRW; | |||
| Structure of human Asc1/CD98hc heteromeric amino acid transporter |
Heteromer Q9NS82; | 100 | 2×NAG; 1×NAG; 1×AJP; 1×NAG; | |||
| Cryo EM map of SLC7A10 in the apo state |
Heteromer Q9NS82; | 100 | 4×NAG; | |||
| Cryo EM map of SLC7A10-SLC3A2 complex in the D-serine bound state |
Heteromer Q9NS82; | 100 | 4×NAG; 1×DSN; | |||
| Overall structure of Erastin-bound xCT-4F2hc complex |
Heteromer Q9UPY5; | 100 | 4×NAG; 1×J9O; 2×PX8; | |||
| Cryo EM structure of System XC- |
Heteromer Q9UPY5; | 100 | 4×NAG; | |||
| Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs |
Heteromer Q9UHI5; | 100 | 4×NAG; | |||
| LAT1-CD98hc complex bound to MEM-108 Fab |
Heteromer Q01650; | 100 | 1×NAG; 5×CLR; 3×NAG; | |||
| CD98hc extracellular domain bound to HBJ127 Fab and MEM-108 Fab |
Heteromer | 100 | 1×NAG; 3×NAG; | |||
| Structure of the high affinity Anticalin P3D11 in complex with the human CD98 heavy chain ectodomain |
Heteromer P80188; | 100 | 2×EDO; | |||
| Structure of complex between TV6.6 and CD98hc ECD |
Heteromer | 100.0 | 1×NAG; 5×EDO; 1×PG4; | |||
| Crystal structure of human CD98 heavy chain extracellular domain in complex with S1-F4 scFv |
Heteromer A0A5C2G3X0; | 100.0 | ||||
| Structure of apo inward-open LAT1-CD98h in nanodisc, focused on TMD |
Heteromer Q01650; | 100 | 3×CLR; 2×LBN; | |||
| Structure of LAT1-CD98hc in complex with BCH, focused on TMD |
Heteromer Q01650; | 100 | 2×CLR; 1×LBN; 1×VU0; | |||
| Structure of LAT1-CD98hc in complex with JPH203, focused on TMD |
Heteromer Q01650; | 100 | 2×CLR; 1×LBN; 1×VRW; | |||
| Structure of LAT1-CD98hc in complex with L-Phe, focused on TMD |
Heteromer Q01650; | 100 | 1×PHE; | |||
| Structure of LAT1-CD98hc in complex with melphalan, focused on TMD |
Heteromer Q01650; | 100 | 1×VUC; | |||
| Structure of apo outward-open LAT1-CD98h in nanodisc, focused on TMD |
Heteromer Q01650; | 100 | ||||
| Cryo EM structure of System XC- in complex with glutamate |
Heteromer Q9UPY5; | 100 | 1×GLU; | |||
| Crystal Structure of human ED-4F2hc | monomer | 100 | 1×ACT; | |||
| Crystal Structure of human ED-4F2hc | monomer | 100 | 1×ZN; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6jmq.1.B | monomer | 0.81 | 100.00 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8a6l.1.A | monomer | 0.84 | 100.00 | |||
| Isoform 3 | 7dsn.1.A | monomer | 0.83 | 98.77 | |||
| Isoform 4 | 7dsn.1.A | monomer | 0.83 | 100.00 | |||
| Isoform 5 | 7dsn.1.A | monomer | 0.82 | 100.00 | |||